Skip to search formSkip to main contentSkip to account menu

Synthetic Human Papillomavirus 16 E6 Peptide

Known as: HPV-16 E6, HPV-16 E6 Peptide, Human Papillomavirus 16 E6 Peptide 
A synthetic peptide sequence of human papillomavirus (HPV) type 16 oncoprotein E6. The E6 oncoprotein is implicated in the tumorigenesis of cervical… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
High-risk human papillomavirus (HPV) is a possible cause of esophageal cancer. However, the molecular pathogenesis of HPV… 
2010
2010
Human papillomaviruses (HPVs) are small DNA viruses, which specifically infect keratinocytes at different body sites. The… 
2010
2010
Cervical cancer is the second most common cancer in women worldwide. Human papillomavirus (HPV) is the primary etiologic agent of… 
Highly Cited
2008
Highly Cited
2008
Human papillomavirus (HPV) infection, particularly type 16, is causally associated with cancer of the uterine cervix. The… 
Highly Cited
2007
Highly Cited
2007
ABSTRACT Human papillomavirus type 16 (HPV-16) has developed numerous ways to modulate host-initiated immune mechanisms. The HPV… 
Highly Cited
2007
Highly Cited
2007
Cyclooxygenase (COX-2) is overexpressed in human papillomavirus (HPV)-induced diseases, including cervical cancer. Although HPV… 
2000
2000
We and others have previously reported that human papillomavirus (HPV)‐16 E6 protein expression sensitizes certain cell types to… 
1998
1998
Certain tumour cells, such as squamous carcinoma cells, express an increased number of epidermal growth factor (EGF) receptors…